Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lynch

Showing results (691-700 of 708) with videos related to

Pageof 71
Sort By:
International Journal of Obesity (2005)|July 16, 2021
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United KingdomMartina Recalde, Elena Roel, Andrea Pistillo, et al.
JMIR Medical Informatics|March 4, 2021
Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation StudyJenna M Reps, Chungsoo Kim, Ross D Williams, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
BMC Medical Research Methodology|January 31, 2022
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international networkRoss D Williams, Aniek F Markus, Cynthia Yang, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A <i>MUC5B</i> Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or MortalityAnurag Verma, Jessica Minnier, Emily S Wan, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.
JAMA Internal Medicine|June 27, 2022
Association of Kidney Comorbidities and Acute Kidney Failure With Unfavorable Outcomes After COVID-19 in Individuals With the Sickle Cell TraitAnurag Verma, Jennifer E Huffman, Lina Gao, et al.
Pageof 71

Showing results (691-700 of 708) with videos related to

Sort By:
Pageof 71
International Journal of Obesity (2005)|July 16, 2021
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United KingdomMartina Recalde, Elena Roel, Andrea Pistillo, et al.
JMIR Medical Informatics|March 4, 2021
Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation StudyJenna M Reps, Chungsoo Kim, Ross D Williams, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
BMC Medical Research Methodology|January 31, 2022
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international networkRoss D Williams, Aniek F Markus, Cynthia Yang, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A <i>MUC5B</i> Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or MortalityAnurag Verma, Jessica Minnier, Emily S Wan, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.
JAMA Internal Medicine|June 27, 2022
Association of Kidney Comorbidities and Acute Kidney Failure With Unfavorable Outcomes After COVID-19 in Individuals With the Sickle Cell TraitAnurag Verma, Jennifer E Huffman, Lina Gao, et al.
Pageof 71